Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Accenture
Dow
Fish and Richardson
Merck
Chinese Patent Office
QuintilesIMS
Medtronic
UBS

Generated: April 22, 2018

DrugPatentWatch Database Preview

DEMECLOCYCLINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Demeclocycline Hydrochloride, and when can generic versions of Demeclocycline Hydrochloride launch?

Demeclocycline Hydrochloride is a drug marketed by Akorn, Amneal Pharm, Barr, Epic Pharma Llc, and Impax Labs. and is included in five NDAs.

The generic ingredient in DEMECLOCYCLINE HYDROCHLORIDE is demeclocycline hydrochloride. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the demeclocycline hydrochloride profile page.
Drug patent expirations by year for DEMECLOCYCLINE HYDROCHLORIDE
Pharmacology for DEMECLOCYCLINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for DEMECLOCYCLINE HYDROCHLORIDE
Synonyms for DEMECLOCYCLINE HYDROCHLORIDE
(2E,4S,4aS,5aS,6S,12aS)-2-[amino(hydroxy)methylidene]-7-chloro-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione hydrochloride
(2Z,4S,4aS,5aS,6S,12aS)-2-[amino(hydroxy)methylidene]-7-chloro-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione hydrochloride
(4S,4AS,5AS,6S,12AR)-7-CHLORO-4-(DIMETHYLAMINO)-1,6,10,11,12A-PENTAHYDROXY-3,12-DIOXO-3,4,4A,5,5A,6,12,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE HYDROCHLORIDE
(4S,4aS,5aS,6S,12aS)-7-chloro-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride
(4S,4aS,5aS,6S,12aS)-7-chloro-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-1,11-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;hydrochloride
[4S-(4|A,4a|A,5a|A,6|A,12a|A)]-7-Chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide Monohydrochloride
[4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha)]-7-chloro-4-(dimethylamino)1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide hydrochloride
064D733
127-33-3 (Parent)
2-Naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-, monohydrochloride
2-Naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-, monohydrochloride, (4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha))-
2-Naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-, monohydrochloride, (4S,4aS,5aS,6S,12aS)-
29O079NTYT
6-Demethyl-7-chlorotetracycline hydrochloride
64-73-3
7-Chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride
7-Chloro-6-demethyltetracycline hydrochloride
AC1NQXVY
AC1O7EUI
AK110703
AKOS015965080
BC219571
C-22948
C21H21ClN2O8.HCl
CAS-64-73-3
CC-26332
CCG-212562
CHEBI:59725
CHEMBL1200474
Clortetrin
CS-3073
D 6140
D00290
Declomycin
Declomycin (TN)
Declomycin hydrochloride
demeclocycline
Demeclocycline (hydrochloride)
Demeclocycline for system suitability, EuropePharmacopoeia (EP) Reference Standard
Demeclocycline HCL
Demeclocycline HCl, pharmaceutical secondary standard, traceable to USP, PhEur, BP
Demeclocycline hydrochloride (internal use)
Demeclocycline hydrochloride (USP)
Demeclocycline hydrochloride [USAN:BAN]
Demeclocycline hydrochloride [USP:BAN]
Demeclocycline hydrochloride, >=90% (HPLC), powder
Demeclocycline hydrochloride, Antibiotic for Culture Media Use Only
Demeclocycline hydrochloride, European Pharmacopoeia (EP) Reference Standard
Demeclocycline hydrochloride, United States Pharmacopeia (USP) Reference Standard
Demeplus
Demethylchlorotetracycline hydrochloride
Demethylchlortetracycline HCl
Demethylchlortetracycline HCl;
Demethylchlortetracycline hydrochloride
Demethylchlortetracycline hydrochloride (JP17)
Demetraciclina
Detracin
Detravis
DSSTox_CID_25252
DSSTox_GSID_45252
DSSTox_RID_80775
DTXSID0045252
EBD31499
EC 200-592-2
EINECS 200-592-2
Elkamicina
EU-0100421
FT-0603113
HMS1570G08
HMS1920C20
HY-17560
KS-00000Q36
Ledermicina
Ledermycin
Ledermycin hydrochloride
Ledermycine
LP00421
LS-93856
Meciclin
MFCD00082371
MLS000028422
MLS001076091
MLS001333687
MolPort-003-666-156
NCGC00016290-01
NCGC00162149-07
NCGC00261106-01
NSC-756708
NSC756708
Opera_ID_242
Pharmakon1600-01500226
PL009946
Prestwick_235
REGID_for_CID_54686764
s4279
SCHEMBL41286
SMR000058439
SPECTRUM1500226
SR-01000075825
SR-01000075825-1
ST24046427
Tox21_110354
Tox21_110354_1
Tox21_500421
UNII-29O079NTYT
Veraciclina
W-109265

US Patents and Regulatory Information for DEMECLOCYCLINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn DEMECLOCYCLINE HYDROCHLORIDE demeclocycline hydrochloride TABLET;ORAL 065389-001 Dec 1, 2008 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Epic Pharma Llc DEMECLOCYCLINE HYDROCHLORIDE demeclocycline hydrochloride TABLET;ORAL 065447-001 Aug 18, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Amneal Pharm DEMECLOCYCLINE HYDROCHLORIDE demeclocycline hydrochloride TABLET;ORAL 065425-002 Feb 27, 2008 AB RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Epic Pharma Llc DEMECLOCYCLINE HYDROCHLORIDE demeclocycline hydrochloride TABLET;ORAL 065447-002 Aug 18, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Covington
Queensland Health
Farmers Insurance
Cipla
US Department of Justice
Express Scripts
QuintilesIMS
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.